BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32141266)

  • 1. Diffuse reflectance spectroscopy to monitor murine colorectal tumor progression and therapeutic response.
    Mundo AI; Greening GJ; Fahr MJ; Hale LN; Bullard EA; Rajaram N; Muldoon TJ
    J Biomed Opt; 2020 Mar; 25(3):1-16. PubMed ID: 32141266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sampling depth of a diffuse reflectance spectroscopy probe for in-vivo physiological quantification of murine subcutaneous tumor allografts.
    Greening G; Mundo A; Rajaram N; Muldoon TJ
    J Biomed Opt; 2018 Aug; 23(8):1-14. PubMed ID: 30152204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal examination of perfusion and angiogenesis markers in primary colorectal tumors shows distinct signatures for metronomic and maximum-tolerated dose strategies.
    Mundo AI; Muhammad A; Balza K; Nelson CE; Muldoon TJ
    Neoplasia; 2022 Oct; 32():100825. PubMed ID: 35901621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors.
    Wang HW; Jiang JK; Lin CH; Lin JK; Huang GJ; Yu JS
    Opt Express; 2009 Feb; 17(4):2805-17. PubMed ID: 19219185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens.
    Tank A; Peterson HM; Pera V; Tabassum S; Leproux A; O'Sullivan T; Jones E; Cabral H; Ko N; Mehta RS; Tromberg BJ; Roblyer D
    Breast Cancer Res; 2020 Mar; 22(1):29. PubMed ID: 32169100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
    Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of interaction between somatic APC mutations and 5-fluorouracil adjuvant chemotherapy in Taiwanese colorectal cancer subjects.
    Chen SP; Wu CC; Lin SZ; Kang JC; Su CC; Chen YL; Lin PC; Chiu SC; Pang CY; Harn HJ
    Am J Clin Oncol; 2009 Apr; 32(2):122-6. PubMed ID: 19307944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy.
    Bess SN; Greening GJ; Rajaram N; Muldoon TJ
    BMC Immunol; 2022 Apr; 23(1):20. PubMed ID: 35461243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of orotate phosphoribosyl transferase among 5-fluorouracil metabolic enzymes in resectable colorectal cancers treated by oral 5-fluorouracil-based adjuvant chemotherapy.
    Ochiai T; Nishimura K; Noguchi H; Kitajima M; Tsukada A; Watanabe E; Nagaoka I; Futagawa S
    Int J Cancer; 2006 Jun; 118(12):3084-8. PubMed ID: 16425285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
    Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
    World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
    Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of GOT1 sensitizes colorectal cancer cells to 5-fluorouracil.
    Hong C; Zheng J; Li X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):835-840. PubMed ID: 28314989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using optical spectroscopy to longitudinally monitor physiological changes within solid tumors.
    Vishwanath K; Yuan H; Barry WT; Dewhirst MW; Ramanujam N
    Neoplasia; 2009 Sep; 11(9):889-900. PubMed ID: 19724683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tumor identification of colorectal liver metastases with diffuse reflectance and fluorescence spectroscopy.
    Tanis E; Evers DJ; Spliethoff JW; Pully VV; Kuhlmann K; van Coevorden F; Hendriks BH; Sanders J; Prevoo W; Ruers TJ
    Lasers Surg Med; 2016 Nov; 48(9):820-827. PubMed ID: 27605447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells.
    Cao Y; Lin Y; Wang D; Pan D; Zhang Y; Jin Y; Zheng C
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1081-1086. PubMed ID: 30155759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phosphoserine phosphatase enhances the anticancer efficacy of 5-fluorouracil in colorectal cancer.
    Li X; Xun Z; Yang Y
    Biochem Biophys Res Commun; 2016 Sep; 477(4):633-639. PubMed ID: 27349874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.